Recent News

• 06.21.2025 - Investor Event on zimislecel (VX-880) at the American Diabetes Association 85th Scientific Sessions
• 06.21.2025 - Investor Event on zimislecel (VX-880) at the American Diabetes Association 85th Scientific Sessions
• 06.12.2025 - Vertex Presents Longer-Term Data at the 2025 European Hematology Association (EHA) Congress Demonstrating Durability of CASGEVY® and Provides Update on Expanding Global Access to CASGEVY
• 06.11.2025 - Vertex Presents Longer-Term Data at the 2025 European Hematology Association (EHA) Congress Demonstrating Durability of CASGEVY® and Provides Update on Expanding Global Access to CASGEVY
• 06.10.2025 - Goldman Sachs 46th Annual Global Healthcare Conference
• 06.10.2025 - Goldman Sachs 46th Annual Global Healthcare Conference
• 06.06.2025 - Vertex Presents New Data on Benefits of ALYFTREK® and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference
• 06.06.2025 - Vertex Presents New Data on Benefits of ALYFTREK® and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference
• 05.30.2025 - Bernstein 41st Annual Strategic Decisions Conference
• 05.30.2025 - Bernstein 41st Annual Strategic Decisions Conference

Recent Filings

• 05.21.2025 - 144 Report of proposed sale of securities
• 05.21.2025 - 144 Report of proposed sale of securities
• 05.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.19.2025 - 8-K Current report
• 05.15.2025 - 144 Report of proposed sale of securities
• 05.15.2025 - 4 Statement of changes in beneficial ownership of securities